A detailed history of Bleakley Financial Group, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 10,469 shares of TMCI stock, worth $105,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,469
Previous 22,142 52.72%
Holding current value
$105,527
Previous $128 Million 39.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$4.66 - $8.78 $54,396 - $102,488
-11,673 Reduced 52.72%
10,469 $77.9 Million
Q3 2024

Oct 16, 2024

SELL
$5.01 - $8.45 $294,557 - $496,809
-58,794 Reduced 72.64%
22,142 $128 Million
Q2 2024

Aug 12, 2024

BUY
$4.17 - $12.62 $337,503 - $1.02 Million
80,936 New
80,936 $538 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $558M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.